Harris WS. N-3 fatty acids and serum lipoproteins: human studies.
Am J Clin Nutr.
1997;65(suppl 5 ):S1645-S1654.
Shekelle RB, Shryock AM, Paul O, et al. Diet, serum cholesterol, and death from coronary heart disease. The Western Electric Study.
N Engl J Med.
1981;304:65-70.
Kromhout D, Bosschieter EB, De Lezenne Coulander C. The inverse relation between fish consumption and 20- year mortality from coronary heart disease.
N Engl J Med.
1985;312:1205-1209.
Harris WS. N-3 fatty acids and serum lipoproteins: human studies.
Am J Clin Nutr.
1997;65(suppl 5):S1645-S1654.
Cobiac L, Clifton PM, Abbey M, et al. Lipid, lipoprotein, and hemostatic effects of fish vs fish-oil n-3 fatty acids in mildly hyperlipidemic males.
Am J Clin Nutr.
1991;53:1210-1216.
Dyerberg J. N-3 fatty acids and coronary artery disease: potentials and problems.
In:
Omega-3, Lipoproteins, and Atherosclerosis.
Paris, France: John Libbey Eurotext; 1996; 27: 251-258.
Lungershausen YK, Abbey M, Nestel PJ, et al. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives.
J Hypertens.
1994;12:1041-1045.
Radack K, Deck C, Huster G. The effects of low doses of n-3 fatty acid supplementation on blood pressure in hypertensive subjects. A randomized controlled trial.
Arch Intern Med.
1991;151:1173-1180.
Singer P, Jaeger W, Wirth M, et al. Lipid and blood pressure-lowering effect of mackerel diet in man.
Atherosclerosis.
1983;49:99-108.
Singer P, Melzer S, Goschel M, et al. Fish oil amplifies the effect of propranolol in mild essential hypertension.
Hypertension.
1990;16:682-691.
Whelton PK, Kumanyika SK, Cook NR, et al. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention.
Am J Clin Nutr.
1997;65(suppl 2):S652-S660.
von Schacky C, Angerer P, Kothny W, et al. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial.
Ann Intern Med.
1999;130:554-562.
Mori TA, Bao DQ, Burke V, et al. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans.
Hypertension.
1999;34:253-260.
Montori VM, Farmer A, Wollan PC, et al. Fish oil supplementation in type 2 diabetes: a quantitative systematic review.
Diabetes Care.
2000;23:1407-1415.
Durrington PN, Bhatnagar D, Mackness MI, et al. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia.
Heart.
2001;85:544-548.
Harris WS. N-3 fatty acids and lipoproteins: comparison of results from human and animal studies.
Lipids.
1996;31:243-252.
Nenseter MS, Osterud B, Larsen T, et al. Effect of Norwegian fish powder on risk factors for coronary heart disease among hypercholesterolemic individuals.
Nutr Metab Cardiovasc Dis.
2000;10:323-330.
van Dam M, Stalenhoef AF, Wittekoek J, et al. Efficacy of concentrated n-3 fatty acids in hypertriglyceridaemia: a comparison with gemfibrozil.
Clin Drug Invest.
2001;21:175-181.
Guallar E, Hennekens CH, Sacks FM, et al. A prospective study of plasma fish oil levels and incidence of myocardial infarction in US male physicians.
J Am Coll Cardiol.
1995;25:387-394.
Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women.
JAMA.
2001;285:304-312.
Shekelle RB, Missell LV, Paul O, et al. Fish consumption and mortality from coronary heart disease [letter].
N Engl J Med.
1985;313:820-821.
Dolecek TA, Granditis G. Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT).
World Rev Nutr Diet.
1991;66:205-216.
Kromhout D, Feskens EJ, Bowles CH. The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population.
Int J Epidemiol.
1995;24:340-345.
Vollset SE, Heuch I, Bjelke E. Fish consumption and mortality from coronary heart disease [letter].
N Engl J Med.
1985;313:820-821.
Curb JD, Reed DM. Fish consumption and mortality from coronary heart disease [letter].
N Engl J Med.
1985;313:821-822.
Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).
Lancet.
1989;2:757-761.
Ascherio A, Rimm EB, Stampfer MJ, et al. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men.
N Engl J Med.
1995;332:977-982.
Leaf A, Jorgensen MB, Jacobs AK, et al. Do fish oils prevent restenosis after coronary angioplasty?
Circulation.
1994;90:2248-2257.
Sacks FM, Stone PH, Gibson CM, et al. Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group.
J Am Coll Cardiol.
1995;25:1492-1498.
[No authors listed]. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.
Lancet.
1999;354:447-455.
de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease.
Lancet.
1994;343:1454-1459.
Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest.
JAMA.
1995;274:1363-1367.
Billman GE, Hallaq H, Leaf A. Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids.
Proc Natl Acad Sci USA.
1994;91:4427-4430.
Sellmayer A, Witzgall H, Lorenz RL, et al. Effects of dietary fish oil on ventricular premature complexes.
Am J Cardiol.
1995;76:974-977.
Nilsen DW, Albrektsen G, Landmark K, et al. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol.
Am J Clin Nutr.
2001;74:50-56.
Angerer P, Stork S, Kothny W, et al. Effect of marine omega-3 fatty acids on peripheral atherosclerosis in patients with coronary artery disease—a randomised 2 year intervention trial [abstract].
Eur Heart J.
2001;22(suppl):162.
James MJ, Cleland LG. Dietary n-3 fatty acids and therapy for rheumatoid arthritis.
Semin Arthritis Rheum.
1997;27:85-97.
Volker D, Fitzgerald P, Major G, et al. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis.
J Rheumatol.
2000;27:2343-2346.
Harel Z, Biro FM, Kottenhahn RK, et al. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents.
Am J Obstet Gynecol.
1996;174:1335-1338.
Deutch B, Jorgensen EB, Hansen JC. Menstrual discomfort in Danish women reduced by dietary supplements of omega-3 PUFA and B
12
(fish oil or seal oil capsules).
Nutr Res.
2000;20:621-631.
Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Arch Gen Psychiatry.
1999;56:407-412.
DiGiacomo RA, Kremer JM, Shah DM. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study.
Am J Med.
1989;86:158-164.
Ringer TV, Hughes GS, Spillers CR, et al. Fish oil blunts the pain response to cold pressor testing in normal males [abstract].
J Am Coll Nutr.
1989;8:435.
Bittiner SB, Cartwright I, Tucker WFG, et al. A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis.
Lancet.
1988;1:378-380.
Tomer A, Kasey S, Connor WE, et al. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids.
Thromb Haemost.
2001;85:966-974.
Walton AJE, Snaith ML, Locniskar M, et al. Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus.
Ann Rheum Dis.
1991;50:463-466.
Donadio JV Jr, Grande JP, Bergstralh EJ, et al. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial.
J Am Soc Nephrol.
1999;10:1772-1777.
Peet M, Brind J, Ramchand CN, et al. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia.
Schizophr Res.
2001;49:243-251.
Belluzzi A, Brignola C, Campieri M, et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease.
N Engl J Med.
1996;334:1557-1560.
Lorenz-Meyer H, Bauer P, Nicolay C, et al. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group).
Scand J Gastroenterol.
1996;31:778-785.
Lorenz R, Weber PC, Szimnau P, et al. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease—a randomized, placebo-controlled, double-blind cross-over trial.
J Intern Med Suppl.
1989;225:225-232.
Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women.
JAMA.
2001;285:301-312.
Hibbeln JR, Salem N Jr. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy.
Am J Clin Nutr.
1995;62:1-9.
Buck AC, Jenkins A, Lingam K, et al. The treatment of idiopathic recurrent urolithiasis with fish oil (EPA) and evening primrose oil (GLA)—a double blind study.
J Urol.
1993;149:253A.
Norrish AE, Skeaff CM, Arribas GLB, et al. Prostate cancer risk and consumption of fish oils: a dietary biomarker-based case-control study.
Br J Cancer.
1999;81:1238-1242.
Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome.
Acta Neurol Scand.
1990;82:209-216.
Warren G, McKendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA.
Acta Neurol Scand.
1999;99:112-116.
Gerbi A, Maixent JM, Ansaldi JL, et al. Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats.
J Nutr.
1999;129:207-213.
Halsted CH, Ghandi G, Tamura T. Sulfasalazine inhibits the absorption of folates in ulcerative colitis.
N Engl J Med.
1981;305:1513-1517.
Aslan A, Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study.
Am J Gastroenterol.
1992;87:432-437.
Almallah YZ, El-Tahir A, Heys SD, et al. Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition.
Eur J Clin Invest.
2000;30:58-65.
Stenson WF, Cort D, Rodgers J, et al. Dietary supplementation with fish oil in ulcerative colitis.
Ann Intern Med.
1992;116:609-614.
Hawthorne AB, Daneshmend TK, Hawkey CJ, et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12-month randomised controlled trial.
Gut.
1992;33:922-928.
Greenfield SM, Green AT, Teare JP, et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis.
Aliment Pharmacol Ther.
1993;7:159-166.
Hawthorne AB, Daneshmend TK, Hawkey CJ, et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12-month randomised controlled trial.
Gut.
1992;33:922-928.
Loeschke K, Ueberschaer B, Pietsch A, et al. n-3 fatty acids only delay early relapse of ulcerative colitis in remission.
Dig Dis Sci.
1996;41:2087-2094.
Thien FC, Woods RK, Walters EH. Oily fish and asthma—a fishy story?
Med J Aust.
1996;164:135-136.
Arm JP, Thien FC, Lee TH. Leukotrienes, fish-oil, and asthma.
Allergy Proc.
1994;15:129-134.
Picado C, Castillo JA, Schinca N, et al. Effects of a fish oil enriched diet on aspirin intolerant asthmatic patients: a pilot study.
Thorax.
1988;43:93-97.
Woods RK, Thien FC, Abramson MJ. Dietary marine fatty acids (fish oil) for asthma.
Cochrane Database Syst Rev.
2000;CD001283.
Dry J, Vincent D. Effect of a fish oil diet on asthma: results of a one-year double-blind study.
Int Arch Allergy Immunol.
1991;95:156-157.
Stenius-Aarniala B, Aro A, Hakulinen A, et al. Evening primrose oil and fish oil are ineffective as supplementary treatment of bronchial asthma.
Ann Allergy.
1989;62:534-547.
Arm J. The effects of dietary supplementation with fish oil on asthmatic responses to antigen.
J Allergy Clin Immunol.
1988;81:183.
Stenius-Aarniala B, Aro A, Hakulinen A, et al. Symptomatic effects of evening primrose oil, fish oil, and olive oil in patients with bronchial asthma.
Ann Allergy.
1985;55:330.
Lee TH, Arm JP. Prospects for modifying the allergic response by fish oil diets.
Clin Allergy.
1986;16:89-100.
Pichard C, Sudre P, Karsegard V, et al. A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. Swiss HIV Cohort Study.
AIDS.
1998;12:53-63.
Scevola D, Oberto L, Faggi A, et al. Fish oil in the treatment of wasting syndrome.
Int Conf AIDS.
1996;11:122.
Nightingale S, Woo E, Smith AD, et al. Red blood cell and adipose tissue fatty acids in mild inactive multiple sclerosis.
Acta Neurol Scand.
1990;82:43-50.
Cunnane SC, Ho SY, Dore-Duffy P, et al. Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis.
Am J Clin Nutr.
1989;50:801-806.
Gallai V, Sarchielli P, Trequattrini A, et al. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids.
J Neuroimmunol.
1995;56:143-153.
Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.
Med Hypotheses.
1986;21:193-200.
Bates D. Dietary lipids and multiple sclerosis.
Ups J Med Sci Suppl.
1990;48:173-187.
Conquer JA, Martin JB, Tummon I, et al. Effect of DHA supplementation on DHA status and sperm motility in asthenozoospermic males.
Lipids.
2000;35:149-154.
Kruger MC, Coetzer H, de Winter R, et al. Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis.
Aging (Milano).
1998;10:385-394.
Bassey EJ, Littlewood JJ, Rothwell MC, et al. Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone.
Br J Nutr.
2000;83:629-635.
Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties.
Prog Neuropsychopharmacol Biol Psychiatry.
2002;26:233-239.
Voigt RG, Llorente AM, Jensen CL, et al. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.
J Pediatr.
2001;139:189-196.
Harris WS. N-3 fatty acids and serum lipoproteins: human studies.
Am J Clin Nutr.
1997;65(suppl 5):S1645-S1654.
Durrington PN, Bhatnagar D, Mackness MI, et al. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia.
Heart.
2001;85:544-548.
Harris WS. N-3 fatty acids and lipoproteins: comparison of results from human and animal studies.
Lipids.
1996;31:243-252.
Nenseter MS, Osterud B, Larsen T, et al. Effect of Norwegian fish powder on risk factors for coronary heart disease among hypercholesterolemic individuals.
Nutr Metab Cardiovasc Dis.
2000;10:323-330.
van Dam M, Stalenhoef AF, Wittekoek J, et al. Efficacy of concentrated n-3 fatty acids in hypertriglyceridaemia: a comparison with gemfibrozil.
Clin Drug Invest.
2001;21:175-181.
Montori VM, Farmer A, Wollan PC, et al. Fish oil supplementation in type 2 diabetes: a quantitative systematic review.
Diabetes Care.
2000;23:1407-1415.
Cobiac L, Clifton PM, Abbey M, et al. Lipid, lipoprotein, and hemostatic effects of fish vs fish-oil n-3 fatty acids in mildly hyperlipidemic males.
Am J Clin Nutr.
1991;53:1210-1216.
Harris WS. N-3 fatty acids and serum lipoproteins: human studies.
Am J Clin Nutr.
1997;65(suppl 5):S1645-S1654.
Dyerberg J. N-3 fatty acids and coronary artery disease: potentials and problems.
In:
Omega-3, Lipoproteins, and Atherosclerosis.
Paris, France: John Libbey Eurotext; 1996; 27: 251-258.
Lungershausen YK, Abbey M, Nestel PJ, et al. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives.
J Hypertens.
1994;12:1041-1045.
Radack K, Deck C, Huster G. The effects of low doses of n-3 fatty acid supplementation on blood pressure in hypertensive subjects. A randomized controlled trial.
Arch Intern Med.
1991;151:1173-1180.
Singer P, Jaeger W, Wirth M, et al. Lipid and blood-pressure-lowering effect of mackerel diet in man.
Atherosclerosis.
1983;49:99-108.
Singer P, Melzer S, Goschel M, et al. Fish oil amplifies the effect of propranolol in mild essential hypertension.
Hypertension.
1990;16:682-691.
Appel LJ, Miller ER III, Seidler AJ, et al. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials.
Arch Intern Med.
1993;153:1429-1438.
Whelton PK, Kumanyika SK, Cook NR, et al. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: Results from phase 1 of the Trials of Hypertension Prevention.
Am J Clin Nutr.
1997;65(suppl 2):S652-S660.
Mori TA, Bao DQ, Burke V, et al. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans.
Hypertension.
1999;34:253-260.
Guallar E, Hennekens CH, Sacks FM, et al. A prospective study of plasma fish oil levels and incidence of myocardial infarction in US male physicians.
J Am Coll Cardiol.
1995;25:387-394.
Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women.
JAMA.
2001;285:304-312.
Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease.
N Engl J Med.
1985;312:1205-1209.
Shekelle RB, Missell LV, Paul O, et al. Fish consumption and mortality from coronary heart disease [letter].
N Engl J Med.
1985;313:820-821.
Dolecek TA, Granditis G. Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT).
World Rev Nutr Diet.
1991;66:205-216.
Kromhout D, Feskens EJ, Bowles CH. The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population.
Int J Epidemiol.
1995;24:340-345.
Vollset SE, Heuch I, Bjelke E. Fish consumption and mortality from coronary heart disease [letter].
N Engl J Med.
1985;313:820-821.
Curb JD, Reed DM. Fish consumption and mortality from coronary heart disease [letter].
N Engl J Med.
1985;313:821-822.
Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).
Lancet.
1989;2:757-761.
Ascherio A, Rimm EB, Stampfer MJ, et al. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men.
N Engl J Med.
1995;332:977-982.
Leaf A, Jorgensen MB, Jacobs AK, et al. Do fish oils prevent restenosis after coronary angioplasty?
Circulation.
1994;90:2248-2257.
Sacks FM, Stone PH, Gibson CM, et al. Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group.
J Am Coll Cardiol.
1995;25:1492-1498.
[No authors listed]. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.
Lancet.
1999;354:447-455.
Angerer P, Stork S, Kothny W, et al. Effect of marine omega-3 fatty acids on peripheral atherosclerosis in patients with coronary artery disease—a randomised 2 year intervention trial [abstract].
Eur Heart J.
2001;22(suppl):162.
de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease.
Lancet.
1994;343:1454-1459.
Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest.
JAMA.
1995;274:1363-1367.
Billman GE, Hallaq H, Leaf A. Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids.
Proc Natl Acad Sci USA.
1994;91:4427-4430.
Sellmayer A, Witzgall H, Lorenz RL, et al. Effects of dietary fish oil on ventricular premature complexes.
Am J Cardiol.
1995;76:974-977.
Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART).
Lancet.
1989;2:757-761.
Nilsen DW, Albrektsen G, Landmark K, et al. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol.
Am J Clin Nutr.
2001;74:50-56.
James MJ, Cleland LG. Dietary n-3 fatty acids and therapy for rheumatoid arthritis.
Semin Arthritis Rheum.
1997;27:85-97.
Volker D, Fitzgerald P, Major G, et al. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis.
J Rheumatol. 2000;27:2343-2346.
Harel Z, Biro FM, Kottenhahn RK, et al. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents.
Am J Obstet Gynecol.
1996;174:1335-1338.
Deutch B, Jorgensen EB, Hansen JC. Menstrual discomfort in Danish women reduced by dietary supplements of omega-3 PUFA and B
12
(fish oil or seal oil capsules).
Nutr Res.
2000;20:621-631.
Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
Arch Gen Psychiatry.
1999;56:407-412.
DiGiacomo RA, Kremer JM, Shah DM. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study.
Am J Med.
1989;86:158-164.
Ringer TV, Hughes GS, Spillers CR, et al. Fish oil blunts the pain response to cold pressor testing in normal males [abstract].
J Am Coll Nutr.
1989;8:435.
Bittiner SB, Cartwright I, Tucker WFG, et al. A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis.
Lancet.
1988;1:378-380.
Soyland E, Funk J, Rajka G, et al. Effect of dietary supplementation with very-long-chain n-3 fatty acids in patients with psoriasis.
N Engl J Med.
1993;328:1812-1816.
Kruger MC, Coetzer H, de Winter R, et al. Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis.
Aging (Milano).
1998;10:385-394.
Bassey EJ, Littlewood JJ, Rothwell MC, et al. Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone.
Br J Nutr.
2000;83:629-635.
Walton AJE, Snaith ML, Locniskar M, et al. Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus.
Ann Rheum Dis.
1991;50:463-466.
Clark WF, Parbtani A, Naylor CD, et al. Fish oil in lupus nephritis: clinical findings and methodological implications.
Kidney Int.
1993;44:75-86.
Clark WF, Parbtani A. Omega-3 fatty acid supplementation in clinical and experimental lupus nephritis.
Am J Kidney Dis.
1994;23:644-647.
Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties.
Prog Neuropsychopharmacol Biol Psychiatry.
2002;26:233-239.
Voigt RG, Llorente AM, Jensen CL, et al. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.
J Pediatr.
2001;139:189-196.
Harris WS. Dietary fish oil and blood lipids.
Curr Opin Lipidol.
1996;7:3-7.
Leaf A, Jorgensen MB, Jacobs AK, et al. Do fish oils prevent restenosis after coronary angioplasty?
Circulation.
1994;90:2248-2257.
Harris WS. Dietary fish oil and blood lipids.
Curr Opin Lipidol.
1996;7:3-7.
Montori VM, Farmer A, Wollan PC, et al. Fish oil supplementation in type 2 diabetes: a quantitative systematic review.
Diabetes Care.
2000;23:1407-1415.
Cobiac L, Clifton PM, Abbey M, et al. Lipid, lipoprotein, and hemostatic effects of fish vs fish-oil n-3 fatty acids in mildly hyperlipidemic males.
Am J Clin Nutr.
1991;53:1210-1216.
Harris WS. Dietary fish oil and blood lipids.
Curr Opin Lipidol.
1996;7:3-7.
Fenton WS, Dickerson F, Boronow J, et al. A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia.
Am J Psychiatry.
2001;158:2071-2074.
Pradalier A, Bakouche P, Baudesson G, et al. Failure of omega-3 polyunsaturated fatty acids in prevention of migraine: a double-blind study versus placebo.
Cephalalgia.
2001;21:818-822.
Singh RB, Niaz MA, Sharma JP, et al. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival.
Cardiovasc Drugs Ther.
1997;11:485-491.
Yam D, et. al. The effect of omega-3 fatty acids on risk factors for cardiovascular diseases.
Harefuah.
2001;140:1156-1158.
Bucher HC, Hengstler P, Schindler C, et al. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials.
Am J Med.
2002;112:298-304.
Schmitz PG, McCloud LK, Reikes ST, et al. Prophylaxis of hemodialysis graft thrombosis with fish oil: double-blind, randomized, prospective trial.
J Am Soc Nephrol.
2002;13:184-190.
Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder.
Am J Psychiatry.
2002;159:477-479.
Vaddadi KS, Soosai E, Chiu E, et al. A randomised, placebo-controlled, double blind study of treatment of Huntington's disease with unsaturated fatty acids.
Neuroreport.
2002;13:29-33.
Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.
Circulation.
2002;105:1897-1903.
Rudra PK, Krokan HE. Cell-specific enhancement of doxorubicin toxicity in human tumour cells by docosahexaenoic acid.
Anticancer Res.
2001;21:29-38.
Hardman WE, Moyer MP, Cameron IL. Consumption of an omega-3 fatty acids product, INCELL AAFA, reduced side-effects of CPT-11 (irinotecan) in mice.
Br J Cancer.
2002;86:983-988.
Middleton SJ, Naylor S, Woolner J, et al. A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis.
Aliment Pharmacol Ther.
2002;16:1131-1135.
Mori TA, Burke V, Puddey IB, et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.
Am J Clin Nutr.
2000;71:1085-1094.
Rambjor GS, Walen AI, Windsor SL Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans.
Lipids.
1996;31(suppl):45-49.
Agren JJ, Hanninen O, Julkunen A, et al. Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels.
Eur J Clin Nutr.
1996;50:765-771.
Childs MT, King IB, Knopp RH. Divergent lipoprotein responses to fish oils with various ratios of eicosapentaenoic acid and docosahexaenoic acid.
Am J Clin Nutr.
1990;52:632-639.
Davidson MH, Maki KC, Kalkowski J, et al. Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled trial.
J Am Coll Nutr.
1997;16:236-243.
Leigh-Firbank EC, Minihane AM, Minihane AM, et al. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses.
Br J Nutr.
2002;87:435-445.
Jacobs MN, Santillo D, Johnston PA, et al. Organochlorine residues in fish oil dietary supplements: comparison with industrial grade oils.
Chemosphere.
1998;37:1709-1721.
Geleijnse JM, Giltay EJ, Grobbee DE, et al. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials.
J Hypertens.
2002;20:1493-1499.
Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs.
Arch Gen Psychiatry.
2002;59:913-919.
Emsley R, Myburgh C, Oosthuizen P, et al. Randomized, placebo-controlled study of ethyl-eicosapentaenoic Acid as supplemental treatment in schizophrenia.
Am J Psychiatry.
2002;159:1596-1598.
Fenton WS, Dickerson F, Boronow J, et al. A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia.
Am J Psychiatry.
2001;158:2071-2074.
Nagakura T, Matsuda S, Shichijyo K, et al. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma.
Eur Respir J.
2000;16:861-865.
Harel Z, Gascon G, Riggs S, et al. Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents.
J Adolesc Health.
2002;31:154-161.
Glueck CJ, McCarren T, Hitzemann R, et al. Amelioration of severe migraine with omega-3 fatty acids: a double-blind, placebo-controlled clinical trial [abstract].
Am J Clin Nutr.
1986;43:710.
Geleijnse JM, Giltay EJ, Grobbee DE, et al. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials.
J Hypertens.
2002;20:1493-1499.
Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs.
Arch Gen Psychiatry.
2002;59:913-919.
Woodman RJ, Mori TA, Burke V, et al. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients.
Atherosclerosis.
2003;166:85-93.
Mangoni AA, Sherwood RA, Swift CG, et al. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial.
J Intern Med.
2002;252:497-503.
Marchioli R, Schweiger C, Tavazzi L, et al. Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
Lipids.
2001;36(suppl):119-126.
Cleland L, James M, Proudman S. The role of fish oils in the treatment of rheumatoid arthritis.
Drugs.
2003;63:845-853.
Zanarini MC, Frankenburg FR. Omega-3 Fatty Acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study.
Am J Psychiatry.
2003;160:167-169.
Barber MD. Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation.
Nutrition.
2001;17:751-755.
Bruera E, Strasser F, Palmer JL, et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study.
J Clin Oncol.
2003;21:129-134.
Helland IB, Smith L, Saarem K, et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age.
Pediatrics.
2003;111:E39-E44.
Smuts CM, Huang M, Mundy D, et al. Plasse T, Major S, Carlson SE. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy.
Obstet Gynecol.
2003;101:469-479.
Olsen SF, Sorensen JD, Secher NJ, et al. Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration.
Lancet.
1992;339:1003-1007.
Blommers J, De Lange-De Klerk ES, Kuik DJ, et al. Evening primrose oil and fish oil for severe chronic mastalgia: A randomized, double-blind, controlled trial.
Am J Obstet Gynecol.
2002;187:1389-1394.
Adam O, Beringer C, Kless T, et al. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis.
Rheumatol Int.
2003;23:27-36.
Marangell LB, Martinez JM, Zboyan HA, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression.
Am J Psychiatry.
2003;160:996-998.
Khan F, Elherik K, Bolton-Smith C, et al. The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects.
Cardiovasc Res.
2003;59:955-962.
Grundt H, Nilsen DW, Mansoor MA, et al. Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties.
Pathophysiol Haemost Thromb.
2003;33:88-95.
Duffy EM, Meenagh GK, McMillan SA, et al. The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus.
J Rheumatol.
2004;31:1551-1556.
Su KP, Huang SY, Chiu CC, et al. Omega-3 fatty acids in major depressive disorder—a preliminary double-blind, placebo-controlled trial.
Eur Neuropsychopharmacol.
2003;13:267-271.
Peet M. Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results.
Prostaglandins Leukot Essent Fatty Acids.
2003;69:477-485.
Stevens L, Zhang W, Peck L, et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors.
Lipids.
2003;38:1007-1021.
Dunstan JA, Mori TA, Barden A, et al. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial.
J Allergy Clin Immunol.
2003;112:1178-1184.
Mickleborough TD, Murray RL, Ionescu AA, et al. Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes.
Am J Respir Crit Care Med.
2003 Aug 6. [Epub ahead of print]
Liu M, Wallmon A, Wallin R, et al. Effects of stable fish oil and simvastatin on plasma lipoproteins in patients with hyperlipidemia.
Nutr Res.
2003;23:1027-1034.
Finnegan YE, Howarth D, Minihane AM, et al. Plant and marine derived (n-3) polyunsaturated fatty acids do not affect blood coagulation and fibrinolytic factors in moderately hyperlipidemic humans.
J Nutr.
2003;133:2210-2213.
Buckley MS, Goff AD, Knapp WE, et al. Fish oil interaction with warfarin.
Ann Pharmacother.
2004;38:50-52.
Harper CR, Edwards MJ, Defilipis AP, et al. Flaxseed Oil Increases the Plasma Concentrations of Cardioprotective (n-3) Fatty Acids in Humans.
J Nutr.
2005;136:83-87.
Romano C, Cucchiara S, Barabino A, et al. Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: A double-blind, randomized, placebo-controlled study.
World J Gastroenterol.
2006;11:7118-21.
Hooper L, Thompson RL, Harrison RA, et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review.
BMJ.
2006 Mar 24. [Epub ahead of print]
Mozaffarian D, Geelen A, Brouwer IA, et al. Effect of fish oil on heart rate in humans. A meta-analysis of randomized controlled trials.
Circulation.
2005 Sep 19. [Epub ahead of print]
Balk EM, Lichtenstein AH, Chung M, et al. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review.
Atherosclerosis.
2006 Mar 9. [Epub ahead of print]
Frangou S, Lewis M, McCrone P, et al. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study.
Br J Psychiatry.
2006;188:46-50.
Burr ML, Dunstan FD, George CH, et al. Is fish oil good or bad for heart disease? Two trials with apparently conflicting results.
J Membr Biol.
2006;206:155-163.
Frangou S, Lewis M, McCrone P, et al. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study.
Br J Psychiatry.
2006;188:46-50.
Knudsen VK, Hansen HS, Osterdal ML, et al. Fish oil in various doses or flax oil in pregnancy and timing of spontaneous delivery: a randomised controlled trial.
BJOG.
2006 Mar 27. [Epub ahead of print]
Yuen AW, Sander JW, Fluegel D, et al. Omega-3 fatty acid supplementation in patients with chronic epilepsy: A randomized trial.
Epilepsy Behav.
2005 Jul 7. [Epub ahead of print]
Berson EL, Rosner B, Sandberg MA, et al. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.
Arch Ophthalmol.
2004;122:1306-1314.
Berson EL, Rosner B, Sandberg MA, et al. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.
Arch Ophthalmol.
2004;122:1297-1305.
Mickleborough TD, Lindley MR, Ionescu AA, Fly AD. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma.
Chest.
2006;129;39-49.
Itomura M, Hamazaki K, Sawazaki S, et al. The effect of fish oil on physical aggression in schoolchildren - a randomized, double-blind, placebo-controlled trial.
J Nutr Biochem.
2005;16:163-171.
Richardson AJ, Montgomery P. The Oxford-Durham Study: A Randomized, Controlled Trial of Dietary Supplementation With Fatty Acids in Children With Developmental Coordination Disorder.
Pediatrics.
2005;115:1360-1366.
Hooper L, Thompson RL, Harrison RA, et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review.
BMJ.
2006 Mar 24. [Epub ahead of print]
Weinstock-Guttman B, Baier M, Park Y, et al. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients.
Prostaglandins Leukot Essent Fatty Acids.
2005;73:397-404.
Bradbury J, Myers SP, Oliver C, et al. An adaptogenic role for omega-3 fatty acids in stress; a randomised placebo controlled double blind intervention study (pilot).
Nutr J.
2004 Nov 28. [Epub ahead of print]
Hooper L, Thompson R, Harrison R, et al. Omega 3 fatty acids for prevention and treatment of cardiovascular disease.
Cochrane Database Syst Rev.
2004;CD003177.
Burr ML, Dunstan FD, George CH, et al. Is fish oil good or bad for heart disease? Two trials with apparently conflicting results.
J Membr Biol.
2006;206:155-63.
Calo L, Bianconi L, Colivicchi F, et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial.
J Am Coll Cardiol.
2005;45:1723-1728.
Sellmayer A, Witzgall H, Lorenz RL, et al. Effects of dietary fish oil on ventricular premature complexes.
Am J Cardiol.
1995;76:974-977.
Geelen A, Brouwer IA, Schouten EG, et al. Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans.
Am J Clin Nutr.
2005;81:416-20.
Raitt MH, Connor WE, Morris C, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial.
JAMA.
2005;293:2884-2891.
Geelen A, Zock PL, Brouwer IA, et al. Effect of n-3 fatty acids from fish on electrocardiographic characteristics in patients with frequent premature ventricular complexes.
Br J Nutr.
2005;93:787-790.
Mozaffarian D, Geelen A, Brouwer IA, et al. Effect of fish oil on heart rate in humans. A meta-analysis of randomized controlled trials.
Circulation.
2005 Sep 19. [Epub ahead of print]
Berbert AA, Kondo CR, Almendra CL, et al. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
Nutrition.
2005;21:131-136.
Frangou S, Lewis M, McCrone P, et al. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study.
Br J Psychiatry.
2006;188:46-50.
Frangou S, Lewis M, McCrone P, et al. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study.
Br J Psychiatry.
2006;188:46-50.
Silvers KM, Woolley CC, Hamilton FC, et al. Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression.
Prostaglandins Leukot Essent Fatty Acids.
2005;72:211-218.
Freund-Levi YF, Eriksdotter-Jonhagen M, Cederholm T, et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD Study.
Arch Neurol.
2006;63:1402-1408.
Harris WS. The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses.
Curr Atheroscler Rep.
2006;8:453-459.
Sundstrom B, Stalnacke K, Hagfors L, et al. Supplementation of omega-3 fatty acids in patients with ankylosing spondylitis.
Scand J Rheumatol.
2006;35:359-362.
Wichmann MW, Thul P, Czarnetzki HD, et al. Evaluation of clinical safety and beneficial effects of a fish oil containing lipid emulsion (Lipoplus, MLF541): data from a prospective, randomized, multicenter trial.
Crit Care Med.
2007 Jan 25. [Epub ahead of print]
Hallahan B, Hibbeln JR, Davis JM, et al. Omega-3 fatty acid supplementation in patients with recurrent self-harm: single-centre double-blind randomised controlled trial.
Br J Psychiatry.
2007;190:118-122.
Schwellenbach LJ, Olson KL, McConnell KJ, et al. The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low-dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides.
J Am Coll Nutr.
2006;25:480-485.
Olsen SF, Osterdal ML, Salvig JD, et al. Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil.
Eur J Clin Nutr.
2007 Feb 7. [Epub ahead of print]
McKenney JM, Sica D. Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia.
Am J Health Syst Pharm.
2007;64:595-605.
Theobald HE, Goodall AH, Sattar N, et al. Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women.
J Nutr.
2007;137:973-978.
Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
Lancet.
2007;369:1090-1098.
Freund-Levi Y, Basun H, Cederholm T, et al. Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
Int J Geriatr Psychiatry.
2007 Jun 21. [Epub ahead of print]
Grenyer BF, Crowe T, Meyer B, et al. Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial.
Prog Neuropsychopharmacol Biol Psychiatry.
2007 Jun 19. [Epub ahead of print]
Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.
J Clin Psychiatry.
2007;68:1056-1061.
Buydens-Branchey L, Branchey M. Long-chain n-3 polyunsaturated fatty acids decrease feelings of anger in substance abusers.
Psychiatry Res.
2007 Sep 25. [Epub ahead of print]
Rogers PJ, Appleton KM, Kessler D, et al. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial.
Br J Nutr.
2007 Oct 24. [Epub ahead of print]
Spadaro L, Magliocco O, Spampinato D, et al. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease.
Dig Liver Dis.
2007 Dec 2.
Bromfield E, Dworetzky B, Hurwitz S, et al. A randomized trial of polyunsaturated fatty acids for refractory epilepsy.
Epilepsy Behav.
2008;12:187-190.
Berger GE, Proffitt TM, McConchie M, et al. Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial.
J Clin Psychiatry.
2007;68:1867-1875.
Jenkins DJ, Josse AR, Beyene J, et al. Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis.
CMAJ.
2008;178:157-164.
Rees AM, Austin MP, Parker GB. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial.
Aust N Z J Psychiatry.
2008;42:199-205.
Jazayeri S, Tehrani-Doost M, Keshavarz SA, et al. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder.
Aust N Z J Psychiatry.
2008;42:192-198.
Van Biervliet S, Devos M, Delhaye T, et al. Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients.
Prostaglandins Leukot Essent Fatty Acids.
2008 Feb 12.
Su KP, Huang SY, Chiu TH, et al. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.
J Clin Psychiatry.
2008 Mar 18.
Galarraga B, Ho M, Youssef HM, et al. Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis.
Rheumatology (Oxford).
2008 Mar 24.
Feagan BG, Sandborn WJ, Mittmann U, et al. Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials.
JAMA.
2008;299:1690-1697.
Hall MN, Chavarro JE, Lee IM, et al. A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men.
Cancer Epidemiol Biomarkers Prev.
2008;17:1136-1143.
Damsgaard CT, Frokiaer H, Andersen AD, et al. Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men.
J Nutr.
2008;138:1061-1066.
Micallef MA, Garg ML. The lipid-lowering effects of phytosterols and (n-3) polyunsaturated fatty acids are synergistic and complementary in hyperlipidemic men and women.
J Nutr.
2008;138:1086-1090.
Ramel A, Martinez A, Kiely M, et al. Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults.
Diabetologia.
2008 May 20.
Appleton KM, Gunnell D, Peters TJ, et al. No clear evidence of an association between plasma concentrations of n-3 long-chain polyunsaturated fatty acids and depressed mood in a non-clinical population.
Prostaglandins Leukot Essent Fatty Acids.
2008 Jun 17
Chong EW, Kreis AJ, Wong TY, et al. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis.
Arch Ophthalmol.
2008;126:826-833.
Mozaffarian D. Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death.
Am J Clin Nutr.
2008;87:1991S-1996S.
Shidfar F, Keshavarz A, Hosseyni S, et al. Effects of omega-3 fatty acid supplements on serum lipids, apolipoproteins and malondialdehyde in type 2 diabetes patients.
East Mediterr Health J.
2008;14:305-313.
Olsen SF, Osterdal ML, Salvig JD, et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry-based follow-up from a randomized controlled trial.
Am J Clin Nutr.
2008;88:167-175.
Erkkila AT, Schwab US, de Mello VD, et al. Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications.
Eur J Nutr.
2008 Jul 29.
van de Rest O, Geleijnse JM, Kok FJ, et al. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial.
Neurology.
2008;71:430-438.
Gissi-Hf Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
Lancet.
2008 Aug 29. [Epub ahead of print]
van de Rest O, Geleijnse JM, Kok FJ, et al. Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial.
Am J Clin Nutr.
2008;88:706-713.
Eslick GD, Howe PR, Smith C, et al. Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis.
Int J Cardiol.
2008 Sep 5.
Emsley R, Niehaus DJ, Oosthuizen PP, et al. Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients: Results from a randomized, placebo-controlled trial.
Psychiatry Res.
2008;161:284-291.
Zhu FS, Liu S, Chen XM, et al. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia.
World J Gastroenterol.
2008;14:6395-6400.
Schubert R, Kitz R, Beermann C, et al. Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge.
Int Arch Allergy Immunol.
2008 Nov 11.
León H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, Tsuyuki RT. Effect of fish oil on arrhythmias and mortality: systematic review.
BMJ.
2008 Dec 23;337:a2931.
Doornbos B, van Goor SA, Dijck-Brouwer DA, Schaafsma A, Korf J, Muskiet FA. Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small population based sample.
Prog Neuropsychopharmacol Biol Psychiatry.
2009;33:49-52.
Zhao YT, Chen Q, Sun YX, Li XB, Zhang P, Xu Y, Guo JH. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials.
Ann Med.
2009;41:301-10.
Hartweg J, Farmer AJ, Holman RR, Neil A. Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes.
Curr Opin Lipidol.
2009;20:30-8.
Amminger GP, Schäfer MR, Papageorgiou K, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
Arch Gen Psychiatry.
2010 Feb;67(2):146.
Makrides M, Gibson RA, McPhee AJ, et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial.
JAMA.
2010;304(15):1675-1683.
Kowey PR, Reiffel JA, Ellenbogen KA, Naccarelli GV, Pratt CM. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial.
JAMA.
2010;304(21):2363-2372. Epub 2010 Nov 15.
Nodari S, Triggiani M, Campia U, et al. Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy.
J Am Coll Cardiol.
2011;57(7):870-879.
Andreeva VA, Kesse-Guyot E, Barberger-Gateau P, Fezeu L, Hercberg S, Galan P.
Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial.
Am J Clin Nutr.
2011;94(1):278-286.
Oliver C, Jahnke N.
Omega-3 fatty acids for cystic fibrosis.
Cochrane Database Syst Rev.
2011;(8):CD002201.
Kiecolt-Glaser JK, Belury MA, Andridge R, et al. Omega-3 supplementation lowers inflammation and anxiety in medical students: A randomized controlled trial.
Brain Behav Immun.
2011 Jul 19. [Epub ahead of print]
Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis.
J Am Acad Child Adolesc Psychiatry.
2011;50(10):991-1000.
Sarris J, Mischoulon D, Schweitzer I. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression.
J Clin Psychiatry.
2011 Aug 9.
Liu T, Korantzopoulos P, Shehata M, Li G, Wang X, Kaul S. Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials.
Heart.
2011;97(13):1034-1040.
Kwak SM, Myung SK, Lee YJ, Seo HG. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med. 2012 Apr 9.
ORIGIN Trial Investigators, Bosch J, Gerstein HC, et al. N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med. 2012;367(4):309-318.
Last reviewed August 2012 by EBSCO CAM Review Board
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.